Cubist Names Dr. Lorianne Masuoka Chief Medical Officer

  Cubist Names Dr. Lorianne Masuoka Chief Medical Officer

Business Wire

LEXINGTON, Mass. -- June 13, 2013

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of
Dr. Lorianne Masuoka to Chief Medical Officer and Senior Vice President,
Clinical Development and Medical Affairs.

Cubist Appoints Dr. Lorianne Masuoka Chief Medical Officer (Photo: Business
Wire)

Cubist Appoints Dr. Lorianne Masuoka Chief Medical Officer (Photo: Business
Wire)

In this role, Dr. Masuoka will lead the strategy, development and
implementation of Cubist’s global clinical programs, while overseeing Clinical
Research, Medical Affairs, Clinical Operations, Biostatistics, Data
Management, and Pharmacovigilance. She will also serve as a member of Cubist’s
executive team.

Dr. Masuoka brings to Cubist more than 25 years of global medical and
development experience, including as Senior Vice President/Chief Medical
Officer at Nektar Therapeutics; Vice President, Clinical Development at
Fiveprime Therapeutics; and Director, Clinical Development at Chiron. In
addition, she held senior clinical positions at Schering, AG and Berlex
Laboratories.

“Dr. Masuoka brings to Cubist a great blend of medical and scientific
leadership, diversity of therapeutic area experience, and global management
skills,” said Steven Gilman, Ph.D., Executive Vice President of Research and
Development and Chief Scientific Officer of Cubist Pharmaceuticals. “She is a
terrific addition to the Cubist team, and we’re very excited to have her join
us as we drive towards our Building Blocks of Growth long-term goals.”

Dr. Masuoka received her medical degree from University of California, Davis,
where she also completed her residency in neurology. She completed her
fellowship at Yale University in New Haven, Connecticut.

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
research, development, and commercialization of pharmaceutical products that
address significant unmet medical needs in the acute care environment. Cubist
is headquartered in Lexington, Mass. Additional information can be found at
Cubist’s web site at www.cubist.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130613005582/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50652057&lang=en

Contact:

INVESTORS:
Cubist Pharmaceuticals, Inc.
Eileen C. McIntyre, 781-860-8533
Vice President, Investor Relations
eileen.mcintyre@cubist.com
or
MEDIA:
Cubist Pharmaceuticals, Inc.
Julie DiCarlo, 781-860-8063
Senior Director, Corporate Communications
julie.dicarlo@cubist.com
 
Press spacebar to pause and continue. Press esc to stop.